Compare

GHRP-2 vs Pinealon

Side-by-side observational reports from PeptIQ users. This compares self-reported patterns — not clinical head-to-head trials.

Last reviewed . By the PeptIQ team.

Observational reporting only — not medical advice. Does not recommend doses, protocols, or treatments.

GHRP-2

1236 community reports

Overall experience

From check-in ratings — separate from side effects logged below. Side effects are logged separately from overall experience. A favorable check-in can still include nausea, fatigue, or injection-site reactions.

Favorable 60% · Mixed 32% · Unfavorable overall 8%

Most reported benefits

Benefits users selected when logging a favorable or mixed check-in.

Mood
159
Focus
165
Sleep quality
31
Lean mass
126
Joint comfort
161

Most logged side effects

Side effects are logged separately from overall experience. A favorable check-in can still include nausea, fatigue, or injection-site reactions.

Fatigue
75
Nausea
64
Water retention
176
Appetite loss
122
Injection site reaction
160

Self-reported dose per injection

Median bucket: 100–200 mcg · Most common: 100–200 mcg

Reports span 25–600 mcg

25–50
2
50–100
13
100–200
22
200–400
11
400–600
2

Anonymized self-reports from PeptIQ users — not prescribing guidance. Buckets group similar logged amounts; open-ended top buckets mean “at least” that dose.

Common discussion topics

timing40stacking18side effects26ghrp-219

How repeat users are trending

Among repeat reporters, 55% said they felt similar to their last entry, 34% more positive, and 20% more negative.

Overall, repeat reporters leaned more positive than their previous entry.

Median gap between entries: 29 days · Based on 272 repeat reporters

Pinealon

1738 community reports

Overall experience

From check-in ratings — separate from side effects logged below. Side effects are logged separately from overall experience. A favorable check-in can still include nausea, fatigue, or injection-site reactions.

Favorable 52% · Mixed 30% · Unfavorable overall 18%

Most reported benefits

Benefits users selected when logging a favorable or mixed check-in.

Appetite control
165
Energy
76
Mood
155
Focus
187
Sleep quality
123

Most logged side effects

Side effects are logged separately from overall experience. A favorable check-in can still include nausea, fatigue, or injection-site reactions.

GI discomfort
81
Dizziness
155
Fatigue
119
Nausea
182
Water retention
123

Self-reported dose per injection

Median bucket: 0.4–0.6 mg · Most common: 0.4–0.6 mg

Reports span 0.05–3 mg

0.05–0.1 mg
2
0.1–0.2 mg
9
0.2–0.4 mg
12
0.4–0.6 mg
21
0.6–1 mg
11
1–2 mg
7
2–3 mg
1

Anonymized self-reports from PeptIQ users — not prescribing guidance. Buckets group similar logged amounts; open-ended top buckets mean “at least” that dose.

Common discussion topics

timing22stacking40side effects18pinealon21

How repeat users are trending

Among repeat reporters, 62% said they felt similar to their last entry, 44% more positive, and 12% more negative.

Overall, repeat reporters leaned more positive than their previous entry.

Median gap between entries: 30 days · Based on 382 repeat reporters

Sources (6)

Published sources linked on the GHRP-2 and Pinealon wiki pages.

  1. PubMed

    Growth hormone-releasing peptides: clinical applications

    Ghigo E, Arvat E, Camanni F. Endocrine. 2008

    Source
    Wiki study page →
  2. PubMed

    Pinealon increases cell viability by suppression of free radical levels and activating proliferative processes

    Khavinson V, Ribakova Y, Kulebiakin K, et al. Rejuvenation research. 2011

    Source
    Wiki study page →
  3. PubMed

    EDR Peptide: Possible Mechanism of Gene Expression and Protein Synthesis Regulation Involved in the Pathogenesis of Alzheimer's Disease

    Khavinson V, Linkova N, Kozhevnikova E, et al. Molecules (Basel, Switzerland). 2020

    Source
    Wiki study page →